Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.
Ontology highlight
ABSTRACT: The receptor activator of NF-κB (RANK) pathway is involved in bone health as well as breast cancer (BC) pathogenesis and progression. Whereas the therapeutic implication of this pathway is established for the treatment of osteoporosis and bone metastases, the application in adjuvant BC is currently investigated. As genetic variants in this pathway have been described to influence bone health, aim of this study was the prognostic relevance of genetic variants in RANK and RANKL. Single nucleotide polymorphisms in RANK(L) (rs1054016/rs1805034/rs35211496) were genotyped and analyzed with regard to bone metastasis-free survival (BMFS), disease-free survival, and overall survival for a retrospective cohort of 1251 patients. Cox proportional hazard models were built to examine the prognostic infl
SUBMITTER: Hein A
PROVIDER: S-EPMC3963378 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA